Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Can Amgen Find a New Engine?

May 01 2007

Related Content

UCB: Will Cimzia Be Enough?

Feb 01 2006

Why EPO Matters

Jul 01 2006

Roche's New EPO: "White Knight" or Wolf in Sheep's Clothing?

Feb 01 2007

Amgen/Abgenix: All About a Drug

Jan 01 2006

Timing is Everything: Biotech Pioneers Push Follow-On Biologics Proposal

Apr 01 2007

Not-For-Profit Makes Business Sense, Too

Jun 01 2006

FibroGen Wins Big Upfront, Keeps US Rights to Oral Anemia Drug

Jun 01 2006

BMS Deals Diabetes Drugs, Solidifies Specialist Stance

Feb 01 2007

CEO Interview: AstraZeneca's David Brennan

Mar 01 2007

Related Companies

Amgen, Inc.

Wyeth

Eli Lilly and Company

Roche Holding AG

Fresenius SE & Co. KGaA

UCB S.A.

Johnson & Johnson

Schering-Plough

Genentech, Inc.

Bristol Myers Squibb Company

Merck & Co., Inc.

Procter & Gamble

Novartis AG

InteKrin Therapeutics, Inc.

Amgen, Inc.

AstraZeneca PLC

Bristol Myers Squibb Company

Amgen, Inc.

Astellas Pharma, Inc.

FibroGen, Inc.

Takeda Pharmaceutical Co. Ltd.

Additional Topics

Strategy Business Strategies Legal Issues Leadership Platform Technologies Regulation Reimbursement BioPharmaceutical

More from Business Strategy

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window